Indogulf Cropsciences Ltd

Indogulf Cropsciences Ltd

₹ 84.0 0.76%
12 Dec - close price
About

Incorporated in 1993, Indogulf Cropsciences Limited is engaged in manufacturing crop protection products, plant nutrients, and biologicals in India.[1]

Key Points

Business Profile[1]
Indogulf Cropsciences Limited is an agrochemical company engaged in the manufacturing and marketing of crop protection products, plant nutrients, and biologicals. It operates across India and exports to over 34 countries. It serves both retail (B2C) and institutional (B2B) customers and also offers contract manufacturing services.

  • Market Cap 531 Cr.
  • Current Price 84.0
  • High / Low 122 / 78.5
  • Stock P/E 15.4
  • Book Value 69.6
  • Dividend Yield 0.00 %
  • ROCE 12.9 %
  • ROE 12.0 %
  • Face Value 10.0

Pros

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 12.6% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2024 Jun 2024 Sep 2024 Mar 2025 Jun 2025 Sep 2025
139 132 233 126 189 248
119 126 205 105 179 216
Operating Profit 20 6 27 21 10 32
OPM % 15% 5% 12% 17% 5% 13%
3 2 1 2 1 2
Interest 3 3 3 4 4 5
Depreciation 3 2 3 3 2 3
Profit before tax 18 2 23 15 5 27
Tax % 28% 34% 27% 35% 17% 24%
13 1 17 10 4 21
EPS in Rs 5.50 0.28 3.42 2.01 0.79 3.27
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
443 486 550 552 590
404 442 501 493 526
Operating Profit 39 45 49 59 64
OPM % 9% 9% 9% 11% 11%
2 4 3 -0 5
Interest 5 6 12 13 15
Depreciation 6 8 10 10 11
Profit before tax 30 36 30 36 45
Tax % 26% 26% 26% 22% 29%
22 26 22 28 31
EPS in Rs 9.48 11.25 9.53 12.00 6.45
Dividend Payout % 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 7%
TTM: 7%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 5%
TTM: -1%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: 13%
Last Year: 12%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 24 24 24 24 49 63
Reserves 130 157 180 208 226 377
79 102 195 159 227 208
178 139 120 154 188 218
Total Liabilities 411 421 519 544 690 866
51 53 69 48 47 48
CWIP 6 9 9 23 58 67
Investments 3 0 0 0 0 15
351 359 440 474 585 736
Total Assets 411 421 519 544 690 866

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
20 -7 -57 53 -15
-10 -10 -19 -5 -40
-9 16 75 -49 61
Net Cash Flow 1 -1 -1 -1 7

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 97 115 117 146 138
Inventory Days 205 167 201 195 260
Days Payable 138 111 79 109 129
Cash Conversion Cycle 164 171 239 232 268
Working Capital Days 62 86 91 111 114
ROCE % 16% 12% 13% 13%

Shareholding Pattern

Numbers in percentages

1 Recently
Jun 2025Sep 2025
96.86% 69.05%
0.00% 0.41%
0.00% 6.23%
3.14% 24.32%
No. of Shareholders 2824,798

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents